Expression of fractalkine (CX3CL1) and Its receptor in endotoxin-induced uveitis

Ophthalmic Research

Volumn 42, Issue 3, 2009, Pages 160-166

  Chu, Liqun ^a   Li, Xiaoxin ^a   Yu, Wenzen ^a   Qian, Tong ^a   Qi, Huijun ^a   Huang, Luzhen ^a   Xu, Yongsheng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Chemoattractant; Chemokine; Endotoxin induced uveitis; Fractalkine

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FOOT PAD; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UVEITIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHEMOKINE CX3CL1; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IRIS; LIPOPOLYSACCHARIDES; RATS; RATS, INBRED LEW; RECEPTORS, CHEMOKINE; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; UVEITIS;

EID: 67749095175     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000230878     Document Type: Article

References (27)

1. Ransohoff RM: Chemokines in neurological trauma models. Ann N Y Acad Sci 2002; 961: 346-349.
2. Marchand F, Perretti M, McMahon SB: Role of the immune system in chronic pain. Nat Rev Neurosci 2005; 6: 521-532.
3. Nagarsekar A, Hasday JD, Singh IS: CXC chemokines: a new family of heat-shock proteins? Immunol Invest 2005; 34: 381-398.
4. Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB: Characterisation of fractalkine in rat brain cells: migratory and activation signals for CX3CR1-expressing microglia. J Immunol 1999; 163: 1628-1635.
5. Streit WJ, Conde JR, Harrison JK: Chemokines and Alzheimer's disease. Neurobiol Aging 2001; 22: 909-913.
6. Wieseler-Frank J, Maier SF, Watkins LR: Glial activation and pathological pain. Neurochem Int 2004; 45: 389-395.
7. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH: Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 2002; 37: 314-327.
8. Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, Foster AC, Naeve GS, Maier SF, Watkins LR: Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 2004; 20: 2294-2302.
9. Damas JK, Boullier A, Waehre T: Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 2005; 25: 2567-2572.
10. Pham VT, Wen L, McCluskey P, Madigan MC, Penfold PL: Human retinal microglia express candidate receptors for HIV-1 infection. Br J Ophthalmol 2005; 89: 753-757.
11. Zujovic V, Benavides J, Vigé X, Carter C, Taupin V: Fractalkine modulates TNF-α secretion and neurotoxicity induced by microglial activation. Glia 2000; 29: 305-315.
12. Rosenbaum JT, McDevitt HO, Guss RB: Endotoxin-induced uveitis in rats as a model for human disease. Nature 1980; 286: 611-613.
13. Chan CC, Tuaillon N, Li Q, Shen DF: Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Ann NY Acad Sci 2000; 923: 141-146.
14. Rosenbaum JT, Raymond W: Monocyte chemotactic activity induced by intravitreal endotoxin. Invest Ophthalmol Vis Sci 1985; 26: 1267-1273.
15. Sluiter W, Pietersma A, Lamers JM: Leukocyte adhesion molecules on the vascular endothelium: Their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J Cardiovasc Pharmacol 1993; 4: 37-44.
16. Mizuno T, Kawanokuchi J, Numata K, Suzumura A: Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 2003; 979: 65-70.
17. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, Pan Y: Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 2002 ; 125: 59-65.
18. Lindia JA, McGowan E, Jochnowitz N, Abbadie C: Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 2005; 6: 434-438.
19. Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996 ; 19: 312-318.
20. Nelson PT, Soma LA, Lavi E: Microglia in diseases of the central nervous system. Ann Med 2002; 34: 491-500.
21. Streit WJ: Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002; 40 : 133-139.
22. Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308: 1314-1318. (Pubitemid 40746128)
23. Town T, Nikolic V, Tan J: The microglial 'activation' continuum: from innate to adaptive responses. J Neuroinflammation 2005; 2: 24.
24. Ng TF, Streilein JW: Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001; 42: 3301-3310.
25. Naskar R, Wissing M, Thanos S: Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest Ophthalmol Vis Sci 2002; 43: 2962-2968.
26. Zhang C, Shen JK, Lam TT, Zeng HY, Chiang SK, Yang F: Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis 2005; 11: 887-895.
27. Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC: MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 2002; 43: 1493-1498.